A study for a 64 year old man who takes Latanoprost, Meclizine - from FDA reports


10 males aged 64 (±5) who take the same drugs are studied. This is a personalized study for a 64 year old male patient who has Glaucoma, Motion Sickness. The study is created by eHealthMe based on reports from FDA.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.


Peer to Peer mobile support

Peer support for this study is available on our Ginger Health app. It's free, anonymous and secure. The app is ideal for people taking multiple medications or having multiple conditions.




On Jan, 14, 2019

10 males aged 64 (±5) who take Latanoprost, Meclizine are studied.


Number of reports submitted per year:

Latanoprost, Meclizine for a 64-year old man.

Information of the patient in this study:

  • Age: 64
  • Gender: male
  • Conditions: Glaucoma, Motion Sickness
  • Drugs taken:
    • Latanoprost (latanoprost)
    • Meclizine (meclizine hydrochloride)

eHealthMe real world results:

Most common drug interactions over time

< 1 month:
n/a
1 - 6 months:
n/a
6 - 12 months:
n/a
1 - 2 years:
n/a
2 - 5 years:
n/a
5 - 10 years:
n/a
10+ years:
n/a
not specified:
  1. Nasal septum deviation (deviated nasal septum)
  2. Fall
  3. Tumor
  4. Haemorrhage (bleeding)
  5. Ear barotrauma (discomfort and possible damage in the ear due to pressure differences between the inside and outside of the eardrum)
  6. Foot deformity (functional disability of foot)
  7. Tinnitus (a ringing in the ears)
  8. Cuts and puncture wounds
  9. Aortic aneurysm (enlargement of an aortic artery caused by a weakening of the artery wall)
  10. Quit smoking

Top conditions involved for these people *:

  1. Stable Angina (a constant chest pain): 5 people, 50.00%
  2. Multiple Myeloma (cancer of the plasma cells): 5 people, 50.00%
  3. Depression : 5 people, 50.00%
  4. Arthritis (form of joint disorder that involves inflammation of one or more joints): 5 people, 50.00%
  5. Arrhythmias (irregular heartbeat): 5 people, 50.00%
  6. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 20.00%
  7. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 10.00%
  8. Pain : 1 person, 10.00%
  9. Osteoporosis (bones weak and more likely to break): 1 person, 10.00%
  10. Muscle Aches (muscle pain): 1 person, 10.00%

Top co-used drugs for these people *:

  1. Folic Acid (6 people, 60.00%)
  2. Zometa (5 people, 50.00%)
  3. Nitrostat (5 people, 50.00%)
  4. Plavix (5 people, 50.00%)
  5. Prednisone (5 people, 50.00%)
  6. Prilosec (5 people, 50.00%)
  7. Magnesium (5 people, 50.00%)
  8. Lorazepam (5 people, 50.00%)
  9. Lisinopril (5 people, 50.00%)
  10. Lexapro (5 people, 50.00%)

* Some reports may have incomplete information.

You are not alone:

What are the drugs?

What are the conditions?



Related studies:

Related publications that referenced our studies

FDA reports used in this study


Recent updates

Recent general studies
Recent personal studies

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Submit your testimonial

  • Please fill in your Testimonial.
  • Please enter a minimum of 10 characters for your Testimonial.
  • Please fill in your Name.

Please wait...

{progressItem}

Thank you!